• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

mRNA COVID-19 疫苗接种后 6 周以上 FDG PET/CT 腋窝淋巴结摄取增加的患病率。

Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination.

机构信息

From the Department of Diagnostic Imaging, Chaim Sheba Medical Center, Sheba Road 2, 52621 Ramat Gan, Israel (Y.E., N.T., Y.A., N.K., L.D., M.E.); and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel (Y.E., N.T., L.D., M.E.).

出版信息

Radiology. 2021 Sep;300(3):E345-E347. doi: 10.1148/radiol.2021210886. Epub 2021 Apr 27.

DOI:10.1148/radiol.2021210886
PMID:33904778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8082565/
Abstract

Ipsilateral avid axillary lymph node uptake at FDG PET/CT persists in 29% (49 of 169) of patients between 7 to 10 weeks after the second dose of the mRNA-based BNT162b2 COVID-19 vaccination.

摘要

在第二剂基于 mRNA 的 BNT162b2 COVID-19 疫苗接种后 7 至 10 周之间，在 FDG PET/CT 中同侧活跃腋窝淋巴结摄取在 29%（169 例中的 49 例）患者中持续存在。

相似文献

1
Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination.mRNA COVID-19 疫苗接种后 6 周以上 FDG PET/CT 腋窝淋巴结摄取增加的患病率。
Radiology. 2021 Sep;300(3):E345-E347. doi: 10.1148/radiol.2021210886. Epub 2021 Apr 27.
2
[F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact.COVID-19 疫苗接种后肿瘤 PET/CT 腋窝淋巴结的 FDG 摄取：频率、强度和潜在的临床影响。
Eur Radiol. 2022 Jan;32(1):508-516. doi: 10.1007/s00330-021-08122-2. Epub 2021 Jun 22.
3
COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake.COVID-19 mRNA 疫苗接种：年龄和免疫状态及其与腋窝淋巴结 PET/CT 摄取的关系。
J Nucl Med. 2022 Jan;63(1):134-139. doi: 10.2967/jnumed.121.262194. Epub 2021 Apr 23.
4
Frequency and Characteristics of Nodal and Deltoid FDG and C-Choline Uptake on PET Performed After COVID-19 Vaccination.COVID-19疫苗接种后PET检查中淋巴结及三角肌FDG和C-胆碱摄取的频率及特征
AJR Am J Roentgenol. 2021 Nov;217(5):1206-1216. doi: 10.2214/AJR.21.25928. Epub 2021 May 19.
5
Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.大腿 COVID-19 疫苗接种后 18F-FDG PET/CT 下膈下游离淋巴结摄取。
Clin Nucl Med. 2022 Mar 1;47(3):275-276. doi: 10.1097/RLU.0000000000003941.
6
F-FDG-Avid Axillary Lymph Nodes After COVID-19 Vaccination.新冠疫苗接种后出现氟代脱氧葡萄糖摄取阳性的腋窝淋巴结
J Nucl Med. 2021 Oct;62(10):1483-1484. doi: 10.2967/jnumed.121.262108. Epub 2021 Mar 19.
7
COVID-19 vaccination induced axillary nodal uptake on [18F]FDG PET/CT.2019冠状病毒病疫苗接种在[18F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（[18F]FDG PET/CT）上引起腋窝淋巴结摄取。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2655-2656. doi: 10.1007/s00259-021-05274-7. Epub 2021 Feb 26.
8
False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization.新冠肺炎疫苗接种后 FDG PET/CT 检查假阳性腋窝淋巴结。
Clin Nucl Med. 2021 Dec 1;46(12):1004-1005. doi: 10.1097/RLU.0000000000003657.
9
COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.COVID-19 疫苗接种相关的 FDG PET/CT 摄取：一个新兴的困境及管理建议。
AJR Am J Roentgenol. 2021 Oct;217(4):975-983. doi: 10.2214/AJR.21.25728. Epub 2021 Mar 1.
10
Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.在 COVID-19 疫苗接种时代，癌症患者 PET/CT 中挑战性的腋窝淋巴结。
Curr Pharm Des. 2024;30(10):798-806. doi: 10.2174/0113816128246329231016091519.

引用本文的文献

1
Examination of iatrogenic FDG accumulation after COVID-19 vaccination.COVID-19 疫苗接种后医源性 FDG 蓄积的检查。
Ann Nucl Med. 2024 Jun;38(6):409-417. doi: 10.1007/s12149-024-01909-5. Epub 2024 Apr 2.
2
Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.在 COVID-19 疫苗接种时代，癌症患者 PET/CT 中挑战性的腋窝淋巴结。
Curr Pharm Des. 2024;30(10):798-806. doi: 10.2174/0113816128246329231016091519.
3
Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine.
比较病毒载体疫苗和 mRNA 疫苗接种后 COVID-19 疫苗 hypermetabolic 淋巴结病的 F-氟脱氧葡萄糖 PET/CT。
Eur J Med Res. 2023 Nov 15;28(1):513. doi: 10.1186/s40001-023-01456-1.
4
[F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer.[F]正电子发射断层扫描融合单光子发射计算机断层扫描解决了雌激素受体阳性乳腺癌中与新冠病毒疫苗相关的高代谢性淋巴结病的诊断难题。
Diagnostics (Basel). 2023 May 25;13(11):1851. doi: 10.3390/diagnostics13111851.
5
Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination.评估基于 mRNA 的 COVID-19 疫苗接种后 FDG PET/CT 成像中的代谢变化。
Turk J Med Sci. 2022 Dec;52(6):1745-1753. doi: 10.55730/1300-0144.5519. Epub 2022 Dec 21.
6
Axillary Lymph Node Uptake on F-FDG PET/CT after COVID-19 Vaccination: A Direct Comparison Study with Influenza Vaccination.新冠疫苗接种后F-FDG PET/CT检查时腋窝淋巴结摄取情况：与流感疫苗接种的直接对比研究
Mol Imaging Radionucl Ther. 2023 Feb 23;32(1):13-19. doi: 10.4274/mirt.galenos.2022.27136.
7
Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and F-FDG PET/CT features.基于病毒载体和mRNA的新冠疫苗接种在局部免疫反应的发生率和严重程度以及F-FDG PET/CT特征方面的比较。
Asia Ocean J Nucl Med Biol. 2023;11(1):4-12. doi: 10.22038/AOJNMB.2022.63110.1443.
8
FDG-PET findings associated with various medical procedures and treatments.与各种医疗程序和治疗相关的 FDG-PET 结果。
Jpn J Radiol. 2023 May;41(5):459-476. doi: 10.1007/s11604-022-01376-w. Epub 2022 Dec 28.
9
Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an F-FDG PET/CT after COVID-19 Vaccination.高代谢同侧锁骨上及腋窝淋巴结病：新冠疫苗接种后行F-FDG PET/CT的最佳时间点
Diagnostics (Basel). 2022 Dec 6;12(12):3073. doi: 10.3390/diagnostics12123073.
10
The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.以色列研究人员在 COVID-19 疫苗相关科学文献中的作用。
Isr J Health Policy Res. 2022 Nov 23;11(1):39. doi: 10.1186/s13584-022-00548-3.